Rossella Belleli
- Genetics top 5%
- Oncology
- Hematology top 10%
- Orthopedics and Sports Medicine top 5%
- Molecular Biology
- Co-authors
- Markus R. JohnRomain SéchaudSarah GloverPatrick GarneroAngela J. RogersJonathan W. LoweryTimothy M. WrightEugène McCloskey
- Topics
- Lung Cancer Diagnosis and Treatment (4 papers)Bone health and treatments (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Rossella Belleli
16 papers receiving 426 citations
Peers
Comparison fields: 5 of 67
- Genetics 166
- Oncology 156
- Hematology 139
- Orthopedics and Sports Medicine 130
- Molecular Biology 97
Countries citing papers authored by Rossella Belleli
This map shows the geographic impact of Rossella Belleli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossella Belleli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossella Belleli more than expected).
Fields of papers citing papers by Rossella Belleli
This network shows the impact of papers produced by Rossella Belleli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossella Belleli. The network helps show where Rossella Belleli may publish in the future.
Co-authorship network of co-authors of Rossella Belleli
This figure shows the co-authorship network connecting the top 25 collaborators of Rossella Belleli. A scholar is included among the top collaborators of Rossella Belleli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossella Belleli. Rossella Belleli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 15 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | 32 | |
| 12 | 32 | |
| 13 | 134 | |
| 14 | 25 | |
| 15 | 34 | |
| 16 | Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. | 114 |
About Rossella Belleli
Rossella Belleli is a scholar working on Genetics, Orthopedics and Sports Medicine and Toxicology, having authored 16 papers that have together received 440 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Bone health and treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Genetics (166 citations), Orthopedics and Sports Medicine (130 citations) and Hematology (139 citations). Rossella Belleli has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Markus R. John, Romain Séchaud, Sarah Glover, Patrick Garnero, Angela J. Rogers, Jonathan W. Lowery, Timothy M. Wright, Eugène McCloskey, Richard Eastell and Renzo Galanello. Their work appears in journals such as Nature Reviews Drug Discovery, Cancer Research and Statistics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.